By the end of this webinar, participants will be able to:
- Understand the role of enzyme replacement therapy in the management of Alpha-Mannosidosis.
- Recognise the psychological symptoms associated with AM and their impact on patients and families.
- Explore strategies for integrating psychological and psychosocial support into patient management.
- Evaluate multidisciplinary approaches that combine medical and mental health care for improved outcomes.
Agenda (CEST):
- 5 min – Introduction – Julia Hennermann
- 25 min – The Role of Enzyme Replacement Therapy in Managing Alpha-Mannosidosis – Julia Hennermann
- 20 min – Psychological Symptoms in Individuals with Alpha-Mannosidosis – Sarah Haupenthal
- 10 min– Q&A – Both Speakers
